The new device is a small, powerful tool which enables visualization of the heart during diagnostic and therapeutic procedures, particularly those involving smaller patients for left heart applications in electrophysiology and interventional cardiology.
Ziyad Hijazi, section chief of pediatric cardiology and professor of pediatrics and medicine at the University of Chicago, said the new catheter will change the way ASD closure procedures are performed in smaller patients.
There will be no need to use transesophageal echocardiography (TEE) in small patients, and the operator will be able to perform the echocardiographic evaluation and the closure simultaneously, therefore the resources in the department will be used more efficiently, he stated.
The product provides visualization of vascular and cardiac anatomy and physiology, measurement of blood flow and visualization of other devices throughout the entire heart.
In addition to the 8F catheter, the company said it will highlight a new approach to optimizing ultrasound imaging using patient specific tissue characteristics, called Native patient specific imaging technology. Siemens claims this offers instant optimization for each individual patient’s blood flow, and reduces keystrokes with hands-free gain control to streamline workflow and improve user ergonomics.
The company has also demonstrated new advancements on the Acuson CV70 cardiovascular system, including the P9-4 pediatric transducer and fourSight view for integrated 3D TEE imaging, to facilitate access to 3D/4D images inside the operating room for review, manipulation and dynamic display of gated 3D datasets using the V5Ms TEE transducer.
